Search Orphan Drug Designations and Approvals
-
Generic Name: | Girentuximab |
---|---|
Date Designated: | 03/22/2001 |
Orphan Designation: | Treatment of renal cell carcinoma. |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 04/29/2021 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Heidelberg Pharma AG 101 Schriesheimer Straße Ladenburg, Baden-Württemberg Germany The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-